Robinson Value Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.67M Sell
5,112
-265
-5% -$145K 1.46% 26
2026
Q2
$2.83M Sell
5,377
-68
-1% -$38.1K 1.52% 26
2026
Q1
$3.06M Sell
5,445
-220
-4% -$141K 1.7% 23
2025
Q4
$3.83M Sell
5,665
-50
-0.9% -$34.1K 2.07% 17
2025
Q3
$3.65M Sell
5,715
-50
-0.9% -$30.3K 2.12% 17
2025
Q2
$3.09M Sell
5,765
-22
-0.4% -$10.5K 1.94% 20
2025
Q1
$2.43M Hold
5,787
– – 1.57% 26
2024
Q4
$2.39M Buy
+5,787
New +$2.54M 1.58% 25

Other funds holding IDXX

Robinson Value Management's IDXX Position: Q3 2026 in Review

Robinson Value Management reduced its Idexx Laboratories (IDXX) stake by 4.9% in Q3 2026, selling an estimated $145K and leaving 5,112 shares worth $2.67M. The position accounts for 1.46% of the portfolio, ranked #26.

Robinson Value Management first reported a position in IDXX in Q4 2024 and has held it in 8 quarters since. The position peaked at $3.83M in Q4 2025. 460 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Robinson Value Management held 5,112 shares of Idexx Laboratories worth $2.67M as of Q3 2026.
  • Robinson Value Management sold 265 Idexx Laboratories shares in Q3 2026, an estimated $145K.
  • Idexx Laboratories made up 1.46% of Robinson Value Management's portfolio in Q3 2026, its #26 holding.
  • Robinson Value Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 8 quarters since.
  • Robinson Value Management's Idexx Laboratories position peaked at $3.83M in Q4 2025.
  • 460 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Robinson Value Management's 13F filing for Q3 2026, filed 20 Oct 2026.